# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-018238
Filing Date
2023-04-13
Accepted
2023-04-13 16:32:37
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEFA14A | ny20007011x2_defa14a.htm | DEFA14A | 11958
2 |  | ny20007011x2_pc01.jpg | GRAPHIC | 480919
3 |  | ny20007011x2_pc02.jpg | GRAPHIC | 374674
| Complete submission text file | 0001140361-23-018238.txt |  | 1191715

Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 23818748
SIC: 2834 Pharmaceutical Preparations